# #162 - Sarah Hallberg, D.O., M.S.: Treating metabolic disease, & a personal journey through cancer

**Channel:** Peter Attia MD
**Upload Date:** 2021-05-17
**URL:** https://www.youtube.com/watch?v=0e6u9JR-o6o
**Duration:** 149 minutes

## Description

View show notes page for this episode: https://bit.ly/3wWvMoE
Become a member to receive exclusive content: https://bit.ly/35uHEmy
Sign up to receive Peter's email newsletter: https://bit.ly/35wfCXZ

Sarah Hallberg is the Medical Director at Virta Health and a physician who has spent nearly two decades treating patients with obesity and type 2 diabetes. In the first half of this episode, Sarah discusses how she became a huge believer in the efficacy of carbohydrate restriction for the treatment of type 2 diabetes through her research and clinical experience. Sarah challenges the common beliefs about the role of dietary fat and carbohydrate on the plasma makeup of fatty acids and triglycerides. She also expresses the importance of understanding early predictors of metabolic illness—highlighting one particular fatty acid as the most important early predictor—before finishing with a discussion about how doctors might be able to personalize patients’ metabolic management in the future. In the second half of this episode, Sarah tells the personal story of her own lung cancer diagnosis. She talks about dealing with her grief, deciding to continue her work while prioritizing her family, and how she devised a plan to extend her survival as long as possible.  

We discuss:
00:00:00 - Intro
00:00:10 - How Sarah discovered the profound impact of carbohydrate restriction for reversing obesity and type 2 diabetes
00:13:30 - Prediabetes and metabolic syndrome: prevalence, early signs, and the importance of treating early
00:27:45 - Overview of fatty acids, how they are metabolized, and understanding what you see in a standard blood panel
00:33:45 - The relationship between diet composition and metabolic markers
00:47:50 - Why palmitoleic acid is such an important biomarker
1:00:30 - The best early indicators of metabolic disease
1:07:45 - Personalized management of metabolic illness
1:16:50 - Sarah’s cancer diagnosis and the beginning of her journey
1:30:00 - The emotional impact of a devastating diagnosis
1:40:30 - Sarah’s plan to extend survival
1:52:15 - Sarah’s aggressive treatment plan
2:05:00 - Life-threatening complications and the return of her cancer
2:18:26 - Sarah’s reflections on her approach to life with chronic cancer and balancing her time


--------
About:

The Peter Attia Drive is a weekly, ultra-deep-dive podcast focusing on maximizing health, longevity, critical thinking…and a few other things. With over 30 million episodes downloaded, it features topics including fasting, ketosis, Alzheimer’s disease, cancer, mental health, and much more.

Peter is a physician focusing on the applied science of longevity. His practice deals extensively with nutritional interventions, exercise physiology, sleep physiology, emotional and mental health, and pharmacology to increase lifespan (delay the onset of chronic disease), while simultaneously improving healthspan (quality of life).

Learn more: https://bit.ly/3K14KjP

Connect with Peter on:
Facebook: http://bit.ly/PeterAttiaMDFB
Twitter: http://bit.ly/PeterAttiaMDTW
Instagram: http://bit.ly/PeterAttiaMDIG

Subscribe to The Drive:
Apple Podcast: http://bit.ly/TheDriveApplePodcasts
Overcast: http://bit.ly/TheDriveOvercast
Spotify: http://bit.ly/TheDriveSpotify
Google Podcasts: http://bit.ly/TheDriveGoogle

## AI Summary

Here's my comprehensive analysis of this powerful episode:

**1. EXECUTIVE SUMMARY**:
This deeply moving episode features Dr. Sarah Hallberg discussing two major topics: her groundbreaking work in treating type 2 diabetes through carbohydrate restriction, and her personal journey with stage 4 lung cancer. The episode demonstrates the intersection of being both a physician and patient, while highlighting healthcare inequities and the importance of patient advocacy. Dr. Hallberg shares her experience maintaining professional work while battling terminal illness, and discusses the impact on her family and approach to limited time.

**2. KEY MEDICAL/SCIENTIFIC POINTS**:
- 88% of adult Americans are not in optimal metabolic health [00:32:15]
- Over 50% of Americans have diabetes or pre-diabetes [00:31:45]
- Non-smoking lung cancer affects 12-14% of lung cancer patients, predominantly thin, athletic women [01:31:00]
- Discussion of palmitoleic acid (16:1) as an important biomarker for metabolic health [00:45:30]
- Detailed explanation of fatty acid metabolism and its relationship to insulin resistance [00:40:00]

**3. HEALTH OPTIMIZATION TIPS**:

Universal Recommendations:
- Monitor blood sugar even before pre-diabetes diagnosis [00:29:15]
- Pay attention to early warning signs of metabolic dysfunction [00:30:00]

Context-specific recommendations:
- For cancer patients: importance of self-advocacy [02:13:10]
- For pre-diabetes: early intervention is critical [00:28:45]

**4. SUPPLEMENTS & MEDICATIONS**:
Medications discussed:
- Tyrosine kinase inhibitors for EGFR mutations [01:35:00]
- Tagrisso (osimertinib) [01:45:00]
- Gemcitabine (Gemzar) [02:05:00]
- Cisplatin [02:04:30]

**5. NUTRITION & DIET**:
- Low carbohydrate diet effectiveness for type 2 diabetes reversal [00:15:00]
- Discussion of saturated fat intake and metabolic health [00:20:00]
- Importance of individual carbohydrate tolerance [02:00:00]

**6. BIOMARKERS & TESTING**:
- Hemoglobin A1c for diabetes diagnosis [00:28:00]
- Palmitoleic acid as metabolic health marker [00:45:00]
- Metabolic syndrome criteria detailed [00:32:30]

**7. NOTABLE QUOTES**:
"I can't settle for less than 11 years" - regarding her goal to see her youngest child graduate [01:45:00]

"Having cancer sucks and I'm still mad about it... I loved my life pre-cancer and I think I was living every minute of it" [02:20:00]

**8. FOLLOW-UP QUESTIONS**:
1. What specific genetic testing should be done before chemotherapy to prevent adverse reactions?
2. How can healthcare systems better support cancer recurrence patients?
3. What role does palmitoleic acid testing have in preventive medicine?

This episode is particularly powerful as it combines cutting-edge metabolic health research with a deeply personal story of facing mortality while maintaining professional impact. Dr. Hallberg's experience highlights both the privileges and challenges within the healthcare system, while providing valuable insights for both practitioners and patients.
